Decreased interleukin 7 responsiveness of T lymphocytes in patients with idiopathic CD4 lymphopenia

Journal of Infectious Diseases

Volumn 205, Issue 9, 2012, Pages 1382-1390

  Puronen, Camille E ^a,c   Thompson, William L ^a   Imamichi, Hiromi ^a   Beq, Stephanie ^b   Hodge, Jessica N ^a,d   Rehm, Catherine ^a   Parker, Raphaelle ^a   Dersimonian, Rebecca ^a   Brenchley, Jason M ^a   Sereti, Irini ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Cytheris SA   (France)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; STAT5 PROTEIN;

ADULT; ALPHA CHAIN; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LYMPHOCYTOPENIA; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

ADULT; BCL-2-ASSOCIATED X PROTEIN; FEMALE; HUMANS; INTERLEUKIN-7; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-7; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; T-LYMPHOCYTOPENIA, IDIOPATHIC CD4-POSITIVE; UP-REGULATION;

EID: 84861553439     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis219     Document Type: Article

References (37)

1. Zonios DI, Falloon J, Bennett JE, et al. Idiopathic CD41 lymphocytopenia: natural history and prognostic factors. Blood 2008; 112:287-94.
2. Bradley LM, Haynes L, Swain SL. IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol 2005; 26:172-6.
3. Kim K, Lee CK, Sayers TJ, Muegge K, Durum SK. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1,-T2, and-T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J Immunol 1998; 160:5735-41.
4. Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 2001; 97:1491-7.
5. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4:1191-8.
6. Li WQ, Jiang Q, Aleem E, Kaldis P, Khaled AR, Durum SK. IL-7 promotes T cell proliferation through destabilization of p27Kip1. J Exp Med 2006; 203:573-82.
7. Hodge JN, Srinivasula S, Hu Z, et al. Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance. Blood 2011; 118:3244-53.
8. Surh CD, Sprent J. Homeostasis of naive and memory T cells. Immunity 2008; 29:848-62.
9. Guimond M, Veenstra RG, Grindler DJ, et al. Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD41 T cells. Nat Immunol 2009; 10:149-57.
10. Bosco N, Agenes F, Ceredig R. Effects of increasing IL-7 availability on lymphocytes during and after lymphopenia-induced proliferation. J Immunol 2005; 175:162-70.
11. Unsinger J, McGlynn M, Kasten KR, et al. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol 2010; 184:3768-79.
12. Mazzucchelli R, Durum SK. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 2007; 7:144-54.
13. Sasson SC, Zaunders JJ, Kelleher AD. The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy. Curr Drug Targets 2006; 7:1571-82.
14. Park JH, Yu Q, Erman B, et al. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 2004; 21: 289-302.
15. Fry TJ, Connick E, Falloon J, et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 2001; 97:2983-90.
16. Napolitano LA, Grant RM, Deeks SG, et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001; 7:73-9.
17. Malaspina A, Moir S, Chaitt DG, et al. Idiopathic CD41 T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood 2007; 109:2086-8.
18. Lee PI, Ciccone EJ, Read SW, et al. Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia. J Infect Dis 2009; 199:1664-70.
19. Laurence J, Mitra D, Steiner M, Lynch DH, Siegal FP, Staiano-Coico L. Apoptotic depletion of CD41 T cells in idiopathic CD41 T lymphocytopenia. J Clin Invest 1996; 97:672-80.
20. Levy Y, Lacabaratz C, Weiss L, et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest 2009; 119: 997-1007.
21. Sereti I, Dunham RM, Spritzler J, et al. IL-7 administration drives T cellcycle entry and expansion in HIV-1 infection. Blood 2009; 113:6304-14.
22. Sportes C, Hakim FT, Memon SA, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 2008; 205:1701-14.
23. Janot-Sardet C, Assouline B, Cheynier R, Morre M, Beq S. A validated assay to measure soluble IL-7 receptor shows minimal impact of IL-7 treatment. J Immunol Methods 2010; 353:115-23.
24. Fry TJ, Mackall CL. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 2005; 174:6571-6.
25. Read SW, Rupert A, Stevens R, O'Shea A, Sereti I. Delayed sample processing leads to marked decreases in measured plasma IL-7 levels. J Acquir Immune Defic Syndr 2006; 42:511-2.
26. Zeng M, Smith AJ, Wietgrefe SW, et al. Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. J Clin Invest 2011; 121:998-1008.
27. Boyman O, Purton JF, Surh CD, Sprent J. Cytokines and T-cell homeostasis. Curr Opin Immunol 2007; 19:320-6.
28. Surh CD, Boyman O, Purton JF, Sprent J. Homeostasis of memory T cells. Immunol Rev 2006; 211:154-63.
29. Kieper WC, Tan JT, Bondi-Boyd B, et al. Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD81 T cells. J Exp Med 2002; 195:1533-9.
30. Alves NL, van Leeuwen EM, Derks IA, van Lier RA. Differential regulation of human IL-7 receptor alpha expression by IL-7 and TCR signaling. J Immunol 2008; 180:5201-10.
31. Ikuta K, Lee HC, Ye SK. Role of the IL-7 receptor in gamma-delta T cell development. Chem Immunol 2001; 79:29-42.
32. Plum J, De Smedt M, Leclercq G. Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD441CD251/-precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture. J Immunol 1993; 150:2706-16.
33. French JD, Roark CL, Born WK, O'Brien R L. {gamma}{delta} T cell homeostasis is established in competition with {alpha}{beta} T cells and NK cells. Proc Natl Acad Sci USA 2005; 102:14741-6.
34. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood 2002; 99:3892-904.
35. Camargo JF, Kulkarni H, Agan BK, et al. Responsiveness of T cells to interleukin-7 is associated with higher CD41 T cell counts in HIV-1-positive individuals with highly active antiretroviral therapyinduced viral load suppression. J Infect Dis 2009; 199:1872-82.
36. Laurence J. T-cell subsets in health, infectious disease, and idiopathic CD41 T lymphocytopenia. Ann Intern Med 1993; 119:55-62.
37. Beq S, Rozlan S, Gautier D, et al. Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques. Blood 2009; 114:816-25.